Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III

References

1. Gromowski, G. D. & Barrett, A. D.(2007). Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366, 349–360.[CrossRef] [Google Scholar]
2. Gromowski, G. D., Barrett, N. D. & Barrett, A. D.(2008). Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. J Virol 82, 8828–8837.[CrossRef] [Google Scholar]
3. Gubler, D. J.(2004). The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis 27, 319–330.[CrossRef] [Google Scholar]
4. Kurane, I.(2007). Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis 30, 329–340.[CrossRef] [Google Scholar]
5. Leong, A. S., Wong, K. T., Leong, T. Y., Tan, P. H. & Wannakrairot, P.(2007). The pathology of dengue hemorrhagic fever. Semin Diagn Pathol 24, 227–236.[CrossRef] [Google Scholar]
6. Matsui, K., Gromowski, G. D., Li, L., Schuh, A. J., Lee, J. C. & Barrett, A. D.(2009). Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III. Virology 384, 16–20.[CrossRef] [Google Scholar]
7. Modis, Y., Ogata, S., Clements, D. & Harrison, S. C.(2005). Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J Virol 79, 1223–1231.[CrossRef] [Google Scholar]
8. Mukhopadhyay, S., Kuhn, R. J. & Rossmann, M. G.(2005). A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3, 13–22.[CrossRef] [Google Scholar]
9. Pang, T., Cardosa, M. J. & Guzman, M. G.(2007). Of cascades and perfect storms: the immunopathogenesis of dengue haemorrhagic fever-dengue shock syndrome (DHF/DSS). Immunol Cell Biol 85, 43–45.[CrossRef] [Google Scholar]
10. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C.(1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291–298.[CrossRef] [Google Scholar]
11. Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L. & Strauss, J. H.(1985). Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229, 726–733.[CrossRef] [Google Scholar]
12. Serafin, I. L. & Aaskov, J. G.(2001). Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies. Arch Virol 146, 2469–2479.[CrossRef] [Google Scholar]
13. Sukupolvi-Petty, S., Austin, S. K., Purtha, W. E., Oliphant, T., Nybakken, G. E., Schlesinger, J. J., Roehrig, J. T., Gromowski, G. D., Barrett, A. D. & other authors(2007). Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 81, 12816–12826.[CrossRef] [Google Scholar]
14. Volk, D. E., Lee, Y. C., Li, X., Thiviyanathan, V., Gromowski, G. D., Li, L., Lamb, A., Beasley, D. W. C., Barrett, A. D. T. & Gorenstein, D. G.(2007). Solution structure of the envelope protein domain III of dengue-4 virus. Virology 364, 147–154.[CrossRef] [Google Scholar]